This Company Wants to Rewrite the Future of Genetic Disease—Without Crispr Gene Editing
Tessera Therapeutics is developing a new class of gene editors capable of precisely plugging in long stretches of DNA—something that Crispr can’t do. https://bit.ly/31RPFhg
By early 2024, a tablet called Opill will be sold in pharmacies without a prescription, making it easier for uninsured and young buyers to access. https://www.wired.com/story/fda-approves-over-the-counter-birth-control-pill-heres-what-to-know/?utm_source=dlvr.it&utm_medium=blogger
Compact, cute, and fairly cheap, Nubia’s Flip 5G could be your first foldable, but the software lets it down. https://www.wired.com/review/nubia-flip-5g/?utm_source=dlvr.it&utm_medium=blogger